Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05111405 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Comparing SBS and LRTI for Treatment of CMC Arthritis

Study acronym: SBSvsLRTI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 28, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 2024 to Feb 2026
    • Study completion date: May 2025 to May 2026
    v5
  2. Study sites: 1 to 2v4
  3. Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: May 2024 to May 2025
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2021 to Jun 20, 2022
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Patient reported outcomes will be collected at 6 and 6 weeks, 3, 6, and 12 months.
Trial Details
NCT Number NCT05111405
Lead Sponsor Fraser Orthopaedic Research Society
Conditions
(from sponsor)		 Arthritis
Related terms Arthritis
Enrollment 138 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov